UFP Technologies Reports 11.6% Revenue Growth in Third Quarter 2026
UFP Technologies (UFPT) reported strong third-quarter results for 2026, with sales reaching $172.4 million, an 11.6% increase year-over-year. The company's growth was driven largely by its medical technology segment, which saw a 12.5% expansion across diverse submarkets including cardiovascular and orthopedic products. Gross margins also improved to 29.4%, up from 27.7% in the previous year. Despite the positive revenue trends, management noted temporary headwinds regarding gross margins due to delays in transferring labor-intensive manufacturing to the Dominican Republic. These delays are attributed to extended customer qualification requirements. However, the company maintains a strong balance sheet with a leverage ratio under 1x and is expanding its credit facility to support larger future acquisitions and organic growth initiatives heading into 2027.
Tickers: $UFPT
Topics: gross margin manufacturing relocation medical technology revenue growth
Read the full article at Motley Fool
Part of the story Geron Corp Reports Third Quarter 2026 Profitability Driven by RYTELO Growth (15 articles)